LEIGHA SHILHANEK: Open Payments
NPI 1114407483 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$395 in 20 payments from 9 companies in 2025. Trend: 2023 $683 · 2024 $709 · 2025 $395
Food & beverage: $395
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $74 |
| GENZYME CORPORATION | 3 | $70 |
| E.R. Squibb & Sons, L.L.C. | 4 | $65 |
| Lilly USA, LLC | 3 | $56 |
| Janssen Biotech, Inc. | 2 | $37 |
| ABBVIE INC. | 2 | $33 |
| Incyte Corporation | 1 | $23 |
| Amgen Inc. | 1 | $19 |
| LEO Pharma Inc. | 1 | $17 |
Products named: DUPIXENT, Sotyktu, TALTZ, COSENTYX, TREMFYA, Rhapsido, OPZELURA, OTEZLA.
Industry payments across AZ — which companies pay providers there.
